Back

Endothelial retargeting of AAV9 in vivo

29 August 2022 (10:15 - 10:55)
Organised by:
Congress Presentation Part of: Metabolic syndrome and vascular dysfunction Gene Therapy, Cell Therapy ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Tarik Bozoglu

University Hospital Rechts der Isar, Munich (Germany)

5 More presentations in this session

Presentation thumbnail
Endothelial-specific deletion of methyltransferase Set7 protects mice from obesity-induced endothelial dysfunction
Doctor J. Sanchez Ceinos (Stockholm, SE)
Abstract Slides
Presentation thumbnail
Targeting Neurofibromin 2 (NF2) Prevents Endothelial Dysfunction in Obesity: A Study in Mice and Humans
Doctor S. Mohammed (Zurich, CH)
Abstract Slides
Presentation thumbnail
Adverse epigenetic signatures driven by histone methyltransferase EZH2 contribute to hyperglycaemia-induced endothelial dysfunction
Doctor J. Sanchez Ceinos (Stockholm, SE)
Abstract Slides
Presentation thumbnail
Monocyte and endothelial dysfunction induced by hyperglycemia is reversed by Empagliflozin mainly through glucose-transport independent mechanisms
Miss D. Semo (Munster, DE)
Abstract Slides
Presentation thumbnail
Impact of metabolic substrate modification on myocardial efficiency in a rat model of obesity and diabetes
Miss J. Virta (Turku, FI)
Abstract Slides

Access the full session

Session thumbnail
Metabolic syndrome and vascular dysfunction

The Event

Event poster

ESC Congress 2022

29 August 2022 10:15 CET
You may be interested in
thumbnail
Congress Presentation
Adeno-associated virus (AAV) 6 provides efficient gene transfer upon intramyocardial injection in vivo
12 April 2024
thumbnail
Congress Presentation
Restoration of endothelial glycocalyx is a promising therapeutic approach for heart failure
1 September 2025
thumbnail
Congress Presentation
Targeted overexpression of regnase-1 in the aorta prevents aneurysm growth in a murine model of Marfan syndrome
29 August 2022
thumbnail
Congress Presentation
Molecular interventions for cardiovascular disease: the bench has arrived at the bedside.
28 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources